You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Multimode Organic Scintillators for Neutron/Gamma Detection

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: DTRA19B003

    There is significant interest in multi-functional materials enabling gamma-ray spectroscopy, neutron/gamma pulse shape discrimination (PSD), ultra-fast response, and time-of-flight (TOF) neutron detection. These materials would be used in a variety of mission scenarios for the localization and monitoring of special nuclear materials. Commercial inorganic scintillators may offer some of these chara ...

    STTR Phase II 2021 Department of DefenseDefense Threat Reduction Agency
  2. Rugged Ultrafast Radiation Hard Scintillators for Nuclear Battlefield

    SBC: CAPESYM INC            Topic: DTRA20B001

    Scintillator radiation detectors offer high sensitivity and relatively accurate radionuclide detection at a reasonable price. However, most of the available commercial scintillators have long decay times ranging from hundreds of nanoseconds to tens of microseconds. As a result, they have limited performance in high dose rate environments such as nuclear battlefields, robotic nuclear weapons test s ...

    STTR Phase I 2021 Department of DefenseDefense Threat Reduction Agency
  3. Fast and Radiation Hard Scintillators for High Dose Detection

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: DTRA20B001

    The event of nuclear explosion generates harsh radiation conditions, evaluation of which is critical in order to protect the military and civilian personnel from serious harm. Due to these harsh conditions only very simple methods of radiation assessment are employed, such as measurement of equivalent dose. Improvements to current instrumentation are sought that would provide energy resolved dose ...

    STTR Phase I 2021 Department of DefenseDefense Threat Reduction Agency
  4. Development of selective calpain-1 inhibitors for chronic pain

    SBC: 1910 GENETICS INC.            Topic: 105

    PROJECT SUMMARY Never in the history of the United States has the unmet medical need to develop novel, non-opioid therapeutics for chronic pain been more urgent than it is today. More than 65 million US adults suffer from chronic pain, resulting in almost $635 billion in annual healthcare costs. Despite their limited efficacy, and potential for addiction, tolerance, and impaired motor performance, ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  5. VAL-0914 Decreases PAO to Protect Against Cardiac Proteinopathies

    SBC: Enable Therapeutics LLC            Topic: NHLBI

    PROJECT SUMMARY Soluble pre-amyloid oligomers (PAO) are the most potent mediators of cytotoxicity, despite common focus on autophagy as a means to clear larger misfolded protein aggregates. Specifically, PAO, rather than aggresomes, are most correlated with desmin-related cardiomyopathy (DRC) caused by an Arg120Gly missense mutation of αB-Crystallin (CryABR120G). In addition to causing DRC, emerg ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  6. Biomimetic size-adaptable heart valve for prosthesis-patient mismatch

    SBC: Autus Valve Technologies, Inc.            Topic: NHLBI

    ABSTRACT The overall goal of this Phase I STTR project is to develop a biomimetic size-adjustable prosthetic heart valve (Autus Size-Adaptable Valve) that can be expanded post-implantation to accommodate changes in blood flow due to somatic growth or cardiac remodelling, to prevent the complications of valve prosthesis-patient mismatch (PPM). By design, all existing surgical prosthetic valves have ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  7. X-ray Visualized Interbody Spacer Indicating Biomechanical Load (X-VISIBL) Fusion Device

    SBC: Spinefrontier, Inc.            Topic: NIAMS

    AbstractSpine disorders, primarily caused by degenerative spine conditions, deformity, tumors, and trauma, affect approximately half of the population aged over 40. To address these disorders, over 457,000 spine fusions were performed in the US in 2011 (6% annual growth), including about 290,000 anterior cervical discectomy and fusions (ACDF). ACDF surgery removes 1-4 intervertebral discs and repl ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  8. Brillouin optical eye scanner prototypes for commercialization

    SBC: INTELON OPTICS, INC.            Topic: 100

    ABSTRACT The overall goal of this STTR project is to commercialize a novel optical eye scanner device capable of measuring the biomechanical properties of tissues via Brillouin light scattering. The Brillouin technology invented in the co-PI’s lab has shown broad potential for improving the diagnosis and treatment of vision disorders. Clinical data obtained with current laboratory systems reveal ...

    STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
  9. Eliminating Acne Through Photo-Inactivation Catalase

    SBC: PULSETHERA CORP            Topic: NIAMS

    PROJECT SUMMARYAcne vulgaris is a skin inflammatory condition affecting 80% of young adults and can frequently induce permanent disfigurement even with appropriate treatment. Acne is caused by C. acnes in the setting of hormonal changes and sebum induction that accompany adolescence. The mainstay of therapeutics consist of eradicating C. acnes and reducing inflammation. However, treatment is prolo ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  10. Using Rendever to improve the quality of life of older adults with cognitive impairments in senior living communities and their family members who live at a distance.

    SBC: RENDEVER, INC.            Topic: NIA

    ABSTRACTThe United States is experiencing a public health crisis on a massive scale due to the number of people with dementia, lack of cures, and challenges associated with caregiving for this population.1,2 until cures for the dementias are discovered, new technologies and interventions are imperative that can reduce the stress and emotional burden of Alzheimer’s disease (AD) and Alzheimer’s ...

    STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government